AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇬
PERTUZUMAB + TRASTUZUMAB in Madagascar
4 products registered with AGMED — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| PHESGO® 1200MG/600MG SI SC BTE(1FL X 15ML) ROCHE PHARMA Solution injectable SC | UNKNOWN-4c01dfb5 | ROCHE PHARMA (SCHWEIZ) AG | active | — |
| PHESGO® 600MG/600MG SI SC BTE(1FL X 10ML) ROCHE PHARMA Solution injectable SC | UNKNOWN-cf533286 | ROCHE PHARMA (SCHWEIZ) AG | active | — |
| PHESGO® 1200MG/600MG SI SC BTE(1FL X 15ML) ROCHE PHARMA Solution injectable SC | UNKNOWN-cb697e89 | ROCHE PHARMA (SCHWEIZ) AG | active | — |
| PHESGO® 600MG/600MG SI SC BTE(1FL X 10ML) ROCHE PHARMA Solution injectable SC | UNKNOWN-e34bfe3a | ROCHE PHARMA (SCHWEIZ) AG | active | — |
PERTUZUMAB + TRASTUZUMAB — AGMED Registration Details
AGMED (Madagascar) has 4 registered products containing PERTUZUMAB + TRASTUZUMAB, of which 4 are currently active. Data is sourced directly from the official AGMED drug register and refreshed daily.
Track PERTUZUMAB + TRASTUZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.